scholarly journals Attitudes toward Pre-symptomatic Testing and Social Services for Families with Huntington's Disease in Japan

1998 ◽  
Vol 8 (3) ◽  
pp. 67-82 ◽  
Author(s):  
Kaori Muto
2020 ◽  
pp. 103-107
Author(s):  
Oliver Quarrell

Treatment of Huntington’s disease (HD) is currently symptomatic and supportive. This is sometimes expressed as saying that there is no treatment to alter the natural history of the condition. There is no specific drug treatment for HD but drugs which are commonly used are dopamine blockers or selective serotonin re-uptake inhibitors (SSRIs). Sometimes mood stabilizers are used. Non drug treatments are also very valuable and should not be overlooked. As important as the drug treatment is the input from other support services such as social services, physiotherapists, and speech therapists. This is not an exhaustive list.


2008 ◽  
Vol 9 (2) ◽  
pp. 65-74 ◽  
Author(s):  
Anthony J. Lechich ◽  
Deborah Lovecky ◽  
Carol Moskowitz ◽  
Sybil Montas ◽  
Ayana Duckett ◽  
...  

This article describes the contours of the residential care placement experience for social service staff, health care providers, and their client families of patients with Huntington’s disease. The purpose of this study was to determine the factors, conditions, and barriers encountered by outpatient clinical staff and families in the transition to skilled nursing care. A Long-Term Care Contact Survey was developed to (a) gather information about long-term care referral sites; (b) determine the factors considered in choosing a facility; (c) describe the factors that hindered the transition to long-term care; (d) describe conditions prior to institutionalization; and (e) determine research interest. The study found that large cohorts of patients with Huntington’s disease in residential care are scarce. A lack of confidence in the available options suggests the need for increased support for educational and social services to facility staff. Speech/swallowing therapy and physical therapy as placement facilitators reflect salient issues of latter stages of the disease, implicating funding support needs. Families facing this transition require long-term guidance for financial, caregiving, and psychosocial issues.


1997 ◽  
Vol 170 (2) ◽  
pp. 146-149 ◽  
Author(s):  
Jane Scourfield ◽  
Jo Soldan ◽  
Jonathon Gray ◽  
Gary Houlihan ◽  
Peter S. Harper

BackgroundPredictive genetic testing for Huntington's disease has been available in Cardiff since 1987 using linked genetic markers, and since 1993 using direct mutation testing, which can also be used as a diagnostic test. During this period there have been numerous referrals that have required liaison with psychiatric services at all stages of the testing programme.MethodA series of cases was selected to highlight issues from both genetic prediction and diagnosis that are relevant to psychiatric practice and have arisen during the testing programme.ResultsIssues have been raised concerning competence to consent to testing in the context of psychotic illness; depression and suicidal ideation in test candidates; requests for testing from third parties such as psychiatrists, social services and the courts; and testing of children.ConclusionsAs genetic testing becomes possible for more disorders the lessons learned from Huntington's disease will provide valuable guidelines for counselling.


2008 ◽  
Vol 35 (S 01) ◽  
Author(s):  
M Mühlau ◽  
A Wohlschläger ◽  
C Gaser ◽  
M Valet ◽  
S Nunnemann ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document